(1)
Zielinski, R. R.; Azad, A. A.; Chi, K. N.; Tyldesley, S. Population-Based Impact on Overall Survival After the Introduction of Docetaxel As Standard Therapy for Metastatic Castration Resistant Prostate Cancer. CUAJ 2014, 8, e520-3.